Literature DB >> 3177551

Anxiety reduction after chorionic villus sampling and genetic amniocentesis.

G E Robinson1, D M Garner, M P Olmsted, J Shime, E M Hutton, B M Crawford.   

Abstract

This study compares anxiety levels in women undergoing prenatal testing by means of chorionic villus sampling versus genetic amniocentesis. Chorionic villus sampling can be performed earlier in a pregnancy (8 to 12 weeks' gestation) but has a higher risk of miscarriage. Randomized to undergo chorionic villus sampling or genetic amniocentesis as part of a trial examining the safety and accuracy of these procedures, the women were studied at four time periods: time 1, before prenatal testing (9 to 12 weeks' gestation); time 2, after the chorionic villus sampling results were received (13 weeks); time 3, before the genetic amniocentesis results were known (18 weeks), and time 4, after all results were known (22 weeks). Although they were still at risk for miscarriage, members of the chorionic villus sampling group showed a sharp drop in anxiety levels immediately after receiving their results. The genetic amniocentesis group remained anxious until the last test time. In summary, prenatal testing by means of chorionic villus sampling resulted in earlier and sustained anxiety reduction.

Entities:  

Mesh:

Year:  1988        PMID: 3177551     DOI: 10.1016/s0002-9378(88)80180-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Amniocentesis and chorionic villus sampling for prenatal diagnosis.

Authors:  Zarko Alfirevic; Kate Navaratnam; Faris Mujezinovic
Journal:  Cochrane Database Syst Rev       Date:  2017-09-04

Review 2.  Amniocentesis and chorionic villus sampling for prenatal diagnosis.

Authors:  Z Alfirevic; K Sundberg; S Brigham
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 3.  Ethical considerations in prenatal diagnosis.

Authors:  E A Gates
Journal:  West J Med       Date:  1993-09

4.  Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.

Authors:  P T Dick
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.